Searchable abstracts of presentations at key conferences in endocrinology

ea0029p755 | Endocrine Disruptors | ICEECE2012

Benzophenone-1 promoted cell growth of BG-1 ovarian cancer cells with estrogen receptors via progression of cell cycle

Park M. , Lee H. , Jeung E. , Choi K.

Benzophenones are organic chemicals widely used as stabilizers to UV light irradiation in plastic surface coatings and food packaging. They have been known that their derivatives appear to have cytotoxic effects. 2-Hydroxy-4-methoxybenzophenone (Benzophenone-3, BP-3) and its metabolite, 2,4-dihydroxybenzophenone (Benzophenone-1, BP-1), are used mostly in the formulation of nail polishes, enamels, bath products, sunscreens and skin care products. In this study, the estrogenic e...

ea0009p161 | Thyroid | BES2005

The titration regimen is as effective and better tolerated than the block-replace regimen in the medical therapy of Graves' hyperthyroidism

Abraham P , Avenell A , Park C , Watson W , Bevan J

IntroductionAntithyroid drugs are widely used in the therapy of hyperthyroidism. This review (update of Cochrane review: Antithyroid drug regimen for treating Graves' hyperthyroidism. In: The Cochrane Library, Issue 4, 2003; with 4 additional trials) assesses the effects of dose, regimen and duration of antithyroid drug therapy for Graves' hyperthyroidism.MethodsThe Cochrane Controlled Trials Register, MEDLIN...

ea0009p176 | Thyroid | BES2005

Iodine deficiency goitre in the United Kingdom - the result of a vegan diet

Park C , Watson W , Bevan J , Abraham P

While iodine deficiency goitre is common worldwide, it is rarely described in the U.K. Vegan diet is the only real way for this deficiency to occur in the U.K. A MEDLINE search from 1966 revealed 1 reported case (Shaikh et al. Transient neonatal hypothyroidism due to a maternal vegan diet; Journal of Pediatric Endocrinology & Metabolism Jan 2003). We have identified 3 cases, which we will describe here.Case 1A 21-year-ol...

ea0092ps1-01-03 | Cancer | ETA2023

Efficacy and safety of radiofrequency ablation in active surveillance candidate for low-risk papillary thyroid microcarcinoma

Kim Ji-Hoon , Ye Lee Ji , joo park young

Purpose: Although some studies presented good outcome of Radiofrequency Ablation (RFA) for Papillary Thyroid microcarcinoma (PTMC), its benefit has not been fully elucidated. The purpose of our study was to report the results from a prospective study investigating efficacy and safety of RFA in active surveillance candidate for low-risk PTMC. Materials and Methods: Since November 2018, RFA has been prospectively performed in active surveillance candidates...

ea0092ps1-05-06 | Thyroid hormone diagnostics 1 | ETA2023

Predictive value of us doppler and microvascular imaging in differentiating benign and malignant thyroid nodules

Yim Younghee , Ik Park Sang , Shin Ahn Hye

Objective: In this study, we investigated the utility of Doppler and microvascular imaging in diagnosing benign and malignant thyroid nodules according to the TI-RADS (Thyroid Imaging Reporting and Data System) and pathologic subtypes of thyroid malignancy.Methods: Total 113 pathologically confirmed thyroid nodules (n =72 (63.7%) benign, n =41 (36.3%) malignant) from103 patients who visited for evaluation of thyroid nodules in single te...

ea0092ps1-07-09 | Thyroid Cancer Diagnosis 1 | ETA2023

Clinical significance of tumor size in gross extrathyroidal extension to strap muscles(T3B) in papillary thyroid carcinoma

Park Joonseon , Kim Kwangsoon , Seong Bae Ja , Kim Jeongsoo

Background: It has been studied that larger tumor size in T3b has a worse prognosis than T3b with smaller tumor size. The present study aims to compare the clinicopathological characteristics among modified T categories and clarify the significance of tumor size in T3b on the DSS of differentiated thyroid carcinoma(DTC).Methods: A total of 6282 patients with DTC who underwent thyroid surgery at a single center were retrospectively analyzed. Patients with...

ea0092ps2-13-10 | Surgery | ETA2023

Transoral robotic thyroidectomy for thyroid diseases - lessons learned from a 1000 consecutive procedures

Park Dawon , Yub Kim Hoon , Jung Kwang-Yoon , Dionigi Gianlorenzo

Background: To evaluate the technical feasibility, effectiveness, and safety of transoral robotic thyroidectomy (TORT), using the da Vinci system through analysis of our series of 1000 consecutive patients.Method: A review of a prospectively designed database at our institute from September 2012 to February 2022 revealed a series of 1000 consecutive TORT patients with preoperative diagnosis of various thyroid diseases. Clinicopathologic characteristics a...

ea0101ps3-23-06 | Clinical thyroid cancer research-3 | ETA2024

Overweight as a risk factor for concomitant thyroid cancer in graves’ disease patients: a retrospective study

Park Joonseon , Seong Bae Ja , Kim Jeongsoo , Kim Kwangsoon

Background: GravesÂ’ disease (GD) is an autoimmune disorder that causes hyperparathyroidism with the presence anti-TSH receptor antibodies (TR-Ab). The incidence of concomitant thyroid cancer in GD varies, and there is no clear consensus on the risk factors. Limited studies have examined the relationship between thyroid cancer in GD and obesity. The aim of the study was to identify the risk factors for concurrent thyroid cancer in GD patients and evaluate the impact of ove...

ea0049ep960 | Pituitary - Clinical | ECE2017

Prevalence and Incidence of pituitary tumors: a nation-wide Population-based study using Korean National Health Insurance claims data

Park Kyeonghye , Choi Junggyu , Park Se Hee , Nam Joo Young , Song Sun Ok , Song Young Duk , Lee Eun Jig

Purpose: We conducted this study to determine the prevalence and incidence of pituitary tumors in South Korea.Methods: This is a nationwide population- based retrospective study. We analysed two national databases, the Korean National Health Insurance (NHI) claims database and Rare Intractable Disease (RID) registration database, which include information on every patients with pituitary tumor diagnosed through uniform criteria from 2009 to 2013. Pituita...

ea0056p806 | Pituitary - Clinical | ECE2018

Association between prolactin level and tumor size reduction at 3 months after cabergoline treatment in patients with macroprolactinoma

Kim Daham , Lee Youngki , Park Se Hee , Park Kyeong Hye , Ryong Ku Cheol , Kim Sun Ho , Lee Eun Jig

Objectives: Prolactin (PRL) normalization after 3 months of Cabergoline (CAB) treatment are useful predictors of responsiveness in patients with prolactinoma. However, differences within the PRL normalization cut-off value have not been identified.Methods: We reviewed the medical records of patients with prolactinomas who were treated with CAB as a primary drug at Severance Hospital. We included patients who had a full dataset of pituitary hormone assays...